Skip to content
MarketScale
‹ Back to Industries

Sciences

Addressing the Lack of Diversity in STEM Careers

Minorities continue to face challenges in pursuing STEM careers due to a lack of access to resources and institutional biases. Early education programs often fail to expose them to technology career paths or inspire a love for technology. The lack of role models within their circles discourages them from pursuing STEM careers and has…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Diversity in StemEducationInstitutional BiasesMentorship
Share

Key takeaways

01

Minorities continue to face challenges in pursuing STEM careers due to a lack of access to resources and institutional biases.

02

Early education programs often fail to expose them to technology career paths or inspire a love for technology.

03

The lack of role models within their circles discourages them from pursuing STEM careers and has…

Minorities continue to face challenges in pursuing STEM careers due to a lack of access to resources and institutional biases. Early education programs often fail to expose them to technology career paths or inspire a love for technology. The lack of role models within their circles discourages them from pursuing STEM careers and has created a pressing need for addressing educational disparities in STEM for underserved youth.

Programs like Challenges and Opportunities for Minorities in STEM Jobs and All-In STEM, founded by Dr. Kenneth Gibbs Jr. and Dr. Ciara Sivels exist with the purpose of addressing educational disparities in STEM for Underserved Youth. The program offers hands-on experience and technical knowledge to students, as well as the opportunity to work in a STEM field of their interest. Olwyn DePutron, the Director of Step IT Up America at UST, another similar program, shares their opinion about providing a path for underrepresented minorities to enter and thrive in STEM careers, where a more diverse and inclusive future for the industry can be created.

Olwyn’s Thoughts:

“In today’s workplace, there’s still a limited number of minorities pursuing STEM careers. The reasons behind this falls into a few buckets. One reason is that in the early education age, there are not a lot of programs available within the schools minorities attend to expose them to the different technology career paths or even to help them to build a love for things technology-wise in addition to the early education.

The familiar circles or relationship circles that minorities grow up in and the individuals they encounter often have jobs outside of technology. There’s often not a role model who would encourage them to pursue STEM careers or to pursue them to build skill sets for STEM careers.

Lastly, the opportunities afforded to them are often done so without the education, without the mentorship, and without guidance. They would not be directed to STEM fields or STEM careers. The Step Up program gives them the education, it gives them the mentorship, and it also gives them an opportunity, an open door to start off that career in technology.

The program allows them to pursue a passion that they may have for technology and train them up in a skillset. From the beginning, all the way to giving them hands-on experience, technical knowledge, and an opportunity to work in a field or in a specific role where they can enhance and build upon the skillset that they learned in the classroom.

In addition, they’re mentored not only by a coach but also a mentor who is within the client organization. Lastly, the client in partnership with us affords them an opportunity to get a role within that organization and continue to build up on their skillset and continue to move forward in a technology field of their interest.”

Article by Galina Mikova.

About the author

S
Sciences

New to MarketScale?

MarketScale is the platform Sciences companies use to turn their own experts into content like this. Want the short overview?

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

At Paris Packaging Week 2026, Tekniplex showcased its latest sustainable materials innovations, emphasizing the intersection of materials science and brand storytelling. The company's booth featured a living wall and digital displays to engage a sustainability-conscious audience, highlighting advanced materials for sustainability and product performance in cosmetics packaging.

  • 01Tekniplex emphasized sustainable materials innovation at Paris Packaging Week 2026.
  • 02The company's booth featured eco-friendly design elements and immersive digital displays.
  • 03Tekniplex highlighted advancements in recyclable sealing systems and materials for cosmetics.

Apr 9, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences